BIOMAT Database Logo BIOMAT Database Logo

[Pharmacologic profile of low molecular weight heparin]. 1986

J Harenberg, and B Würzner, and R Zimmermann, and G Schettler

UI MeSH Term Description Entries
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect

Related Publications

J Harenberg, and B Würzner, and R Zimmermann, and G Schettler
Biochemical and pharmacologic profile of low molecular weight heparin (LU 47311, Clivarin).
January 1993, Seminars in thrombosis and hemostasis,
J Harenberg, and B Würzner, and R Zimmermann, and G Schettler
Pharmacologic profile of a low-molecular-weight heparin depolymerized by gamma-irradiation.
January 1995, Seminars in thrombosis and hemostasis,
J Harenberg, and B Würzner, and R Zimmermann, and G Schettler
Biochemical and pharmacologic profile of defined molecular weight fractions of heparin.
January 1993, Seminars in thrombosis and hemostasis,
J Harenberg, and B Würzner, and R Zimmermann, and G Schettler
Low-molecular-weight heparins: pharmacologic profile and product differentiation.
September 1998, The American journal of cardiology,
J Harenberg, and B Würzner, and R Zimmermann, and G Schettler
Pharmacologic therapy for the management of thrombosis: unfractionated heparin or low-molecular-weight heparin?
January 2005, Clinical cornerstone,
J Harenberg, and B Würzner, and R Zimmermann, and G Schettler
Pharmacologic profile of a low molecular weight heparin (enoxaparin): experimental and clinical validation of the prophylactic antithrombotic effects.
January 1990, Acta chirurgica Scandinavica. Supplementum,
J Harenberg, and B Würzner, and R Zimmermann, and G Schettler
[Low molecular weight heparin].
January 1990, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
J Harenberg, and B Würzner, and R Zimmermann, and G Schettler
[Low molecular weight heparin].
May 1985, La Revue du praticien,
J Harenberg, and B Würzner, and R Zimmermann, and G Schettler
[Low molecular weight heparin].
January 1988, La Revue de medecine interne,
J Harenberg, and B Würzner, and R Zimmermann, and G Schettler
Low-molecular-weight heparin.
May 1994, The Medical clinics of North America,
Copied contents to your clipboard!